Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Reduced Response to Sitagliptin in Type 2 Diabetes
NCT01449747Phase 4Completed
- Sponsor
- The Catholic University of Korea
- Start
- Dec 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by The Catholic University of Korea. Started Dec 2011; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01449747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449747.